Publisher： John Wiley & Sons Inc
E-ISSN： 2211-5463|4|1|755-762
ISSN： 2211-5463
Source： FEBS Open Bio, Vol.4, Iss.1, 2014-01, pp. : 755-762
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Low‐density lipoprotein receptor (LDLR) mediates hepatic clearance of plasma cholesterol; proprotein convertase subtilisin/kexin 9 (PCSK9) opposes this clearance by promoting LDLR degradation. The plant flavonoid quercetin‐3‐β‐d‐glucoside (Q3G) has been shown to reduce hypercholesterolemia in experimental animals. Here, we examined how it affects LDLR and PCSK9 expression as well as LDL uptake by human Huh7 hepatocytes. At low micromolar concentrations, Q3G increased LDLR expression, reduced PCSK9 secretion, and stimulated LDL uptake. It also diminished intracellular sortilin, a sorting receptor known to facilitate PCSK9 secretion. Thus, as an LDLR inducer and a PCSK9 anti‐secretagogue, Q3G may represent an effective anti‐cholesterolemic agent.
Related content
By Cicero Arrigo FG Tartagni Elisa Ertek Sibel
Expert Opinion on Biological Therapy, Vol. 14, Iss. 6, 2014-06 ,pp. :
Access to resources
Recommend
By Minami M. Kume N. Kataoka H. Morimoto M. Hayashida K. Sawamura T. Masaki T. Kita T.
Biochemical and Biophysical Research Communications, Vol. 272, Iss. 2, 2000-06 ,pp. :
By Terao Junji Yamaguchi Sachiyo Shirai Mutsuko Miyoshi Mariko Moon Jae-Hak Oshima Syunji Inakuma Takahiro Tsushida Tojiro Kato Yoji
Free Radical Research, Vol. 35, Iss. 6, 2001-01 ,pp. :
By Chan P.C. Lafreniere R. Parsons H.G.
Biochemical and Biophysical Research Communications, Vol. 235, Iss. 1, 1997-06 ,pp. :